Long-term follow-up of ulcerative colitis in Taiwan

Journal of the Chinese Medical Association

Volumn 75, Issue 4, 2012, Pages 151-155

  Wei, Shu Chen ^a   Shieh, Ming Jium ^a   Chang, Ming Chu ^a   Chang, Yu Ting ^a   Wang, Cheng Yi ^a   Wong, Jau Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Colorectal cancer; Primary sclerosing cholangitis; Taiwan; Ulcerative colitis

Indexed keywords

BUDENOFALK;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLON; COLON CANCER; DISEASE SEVERITY; DYSPLASIA; FEMALE; FOLLOW UP; HEMATOCHEZIA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PROCTITIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TAIWAN; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84860240669     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2012.02.017     Document Type: Article

References (24)

1. Yang S.K., Yun S., Kim J.H., Park J.Y., Kim H.Y., Kim Y.H., et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008, 14:542-549.
2. Yang S.K., Hong W.S., Min Y.I., Kim H.Y., Yoo J.Y., Rhee P.L., et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol 2000, 15:1037-1042.
3. Yoshida Y., Murata Y. Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. Med Clin North Am 1990, 74:67-90.
4. Chow D.K., Leong R.W., Tsoi K.K., Ng S.S., Leung W.K., Wu J.C., et al. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol 2009, 104:647-654.
5. Ling K.L., Ooi C.J., Luman W., Cheong W.K., Choen F.S., Ng H.S. Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state. J Clin Gastroenterol 2002, 35:144-148.
6. Asakura K., Nishiwaki Y., Inoue N., Hibi T., Watanabe M., Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol 2009, 44:659-665.
7. Ouyang Q., Tandon R., Goh K.L., Ooi C.J., Ogata H., Fiocchi C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 2005, 21:408-413.
8. Ooi C.J., Fock K.M., Makharia G.K., Goh K.L., Ling K.L., Hilmi I., et al. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol Hepatol 2010, 25:453-468.
9. Yao T., Matsui T., Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000, 43:S85-S93.
10. Hsiao C.H., Wei S.C., Wong J.M., Lai H.S., Chang M.H., Ni Y.H. Pediatric Crohn disease: clinical and genetic characteristics in Taiwan. J Pediatr Gastroenterol Nutr 2007, 44:342-346.
11. Wei S.C., Ni Y.H., Yang H.I., Su Y.N., Chang M.C., Chang Y.T., et al. A hospital-based study of clinical and genetic features of Crohn's disease. J Formos Med Assoc 2011, 110:600-606.
12. Fujimoto T., Kato J., Nasu J., Kuriyama M., Okada H., Yamamoto H., et al. Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur J Gastroenterol Hepatol 2007, 19:229-235.
13. Hiwatashi N., Yao T., Watanabe H., Hosoda S., Kobayashi K., Saito T., et al. Long-term follow-up study of ulcerative colitis in Japan. J Gastroenterol 1995, 30(Suppl):13-16.
14. Park S.H., Kim Y.M., Yang S.K., Kim S.H., Byeon J.S., Myung S.J., et al. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007, 13:278-283.
15. Wang Y., Ouyang Q. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol 2007, 22:1450-1455.
16. Kim B.J., Yang S.K., Kim J.S., Jeen Y.T., Choi H., Han D.S., et al. Trends of ulcerative colitis-associated colorectal cancer in Korea: A KASID study. J Gastroenterol Hepatol 2009, 24:667-671.
17. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003, 18(Suppl):1-5.
18. Jess T., Loftus E.V., Velayos F.S., Winther K.V., Tremaine W.J., Zinsmeister A.R., et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol 2007, 102:829-836.
19. Eaden J.A., Mayberry J.F. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002, 51(Suppl):V10-V12.
20. Neumann H, Vieth M., Langner C., Neurath M.F., Mudter J. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol 2011, 17:3184-3191.
21. Loftus E.V. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr Gastroenterol Rep 2004, 6:506-513.
22. Zeitz J., Mullhaupt B., Fruehauf H., Rogler G., Vavricka S.R. Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone. Hepatology 2009, 50:653-654.
23. Hsu C., Wei S.C., Cheng A.L., Chen P.J. Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy. Hepatology 2009, 50:654-655.
24. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45:507-539.